日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy

用于癌症治疗的靶向突变型KRAS肽的CAR-T细胞

Alexander Benton ,Jiageng Liu ,Mathilde A Poussin ,Andrea Lang Goldgewicht ,Madhara Udawela ,Adham S Bear ,Nils Wellhausen ,Beatriz M Carreno ,Pete M Smith ,Matthew D Beasley ,Ben R Kiefel ,Daniel J Powell Jr

LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma

LOXHD1是尤文氏肉瘤的肿瘤融合调节抗原

Tatiana Blanchard ,Pouya Faridi ,Chong Xu ,Adham S Bear ,Reyaz Ur Rasool ,Grace Huang ,Terry C C Lim ,Rochelle Ayala ,Khatuna Gabunia ,Mei Ji ,Avery D Posey Jr ,John Scholler ,Irfan A Asangani ,Anthony W Purcell ,Gerald P Linette ,Carl H June ,Beatriz M Carreno

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors

靶向KRASG12V的天然TCR对人类实体瘤表现出良好的特异性和敏感性。

Adham S Bear ,Rebecca B Nadler ,Mark H O'Hara ,Kelsey L Stanton ,Chong Xu ,Robert J Saporito ,Andrew J Rech ,Miren L Baroja ,Tatiana Blanchard ,Maxwell H Elliott ,Michael J Ford ,Richard Jones ,Shivang Patel ,Andrea Brennan ,Zachary O'Neil ,Daniel J Powell Jr ,Robert H Vonderheide ,Gerald P Linette ,Beatriz M Carreno

Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations

针对KRAS突变衍生抗原的免疫疗法策略的现状与展望

Linette, Gerald P; Bear, Adham S; Carreno, Beatriz M

Expression of inducible factors reprograms CAR-T cells for enhanced function and safety

诱导因子的表达可对CAR-T细胞进行重编程,从而增强其功能和安全性。

Anže Smole ,Alexander Benton ,Mathilde A Poussin ,Monika A Eiva ,Claudia Mezzanotte ,Barbara Camisa ,Beatrice Greco ,Prannda Sharma ,Nicholas G Minutolo ,Falon Gray ,Adham S Bear ,Miren L Baroja ,Casey Cummins ,Chong Xu ,Francesca Sanvito ,Andrea Lang Goldgewicht ,Tatiana Blanchard ,Alba Rodriguez-Garcia ,Michael Klichinsky ,Chiara Bonini ,Carl H June ,Avery D Posey Jr ,Gerald P Linette ,Beatriz M Carreno ,Monica Casucci ,Daniel J Powell Jr

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

对突变型KRAS表位的生化和功能表征验证了该癌蛋白作为免疫靶向靶点的有效性。

Adham S Bear,Tatiana Blanchard,Joseph Cesare,Michael J Ford,Lee P Richman,Chong Xu,Miren L Baroja,Sarah McCuaig,Christina Costeas,Khatuna Gabunia,John Scholler,Avery D Posey Jr,Mark H O'Hara,Anze Smole,Daniel J Powell Jr,Benjamin A Garcia,Robert H Vonderheide,Gerald P Linette,Beatriz M Carreno

Challenges and Opportunities for Pancreatic Cancer Immunotherapy

胰腺癌免疫疗法的挑战与机遇

Bear, Adham S; Vonderheide, Robert H; O'Hara, Mark H

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer

胰腺癌中肿瘤来源的髓系细胞趋化因子和T细胞排斥

Vonderheide, Robert H; Bear, Adham S

Bibliometric analysis of worldwide scientific literature in mobile - health: 2006-2016

2006-2016年全球移动健康领域科学文献的文献计量分析

Sweileh, Waleed M; Al-Jabi, Samah W; AbuTaha, Adham S; Zyoud, Sa'ed H; Anayah, Fathi M A; Sawalha, Ansam F

Bibliometric Analysis of Worldwide Publications on Antimalarial Drug Resistance (2006-2015)

全球抗疟药物耐药性相关出版物的文献计量分析(2006-2015)

Sweileh, Waleed M; Al-Jabi, Samah W; Sawalha, Ansam F; AbuTaha, Adham S; Zyoud, Sa'ed H